Industries
Showing 1271–1280 of 1332 results
-
Multi-Drug Resistance (MDR) Antibiotics Market in China 2021
The multi-drug resistance (MDR) antibiotics market in China in terms of revenue is set to grow by US$ 3 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the multi-drug resistance (MDR) antibiotics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Cleanroom Facility Market in China 2021
The cleanroom facility market in China in terms of revenue is set to grow by US$ 11 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the cleanroom facility market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Ulcerative Colitis (UC) Market in China 2021
The ulcerative colitis (UC) market in China in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 16.5% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the ulcerative colitis (UC) market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Pulmonary Arterial Hypertension (PAH) Market in China 2021
The pulmonary arterial hypertension (PAH) market in China in terms of revenue is set to grow by US$ 787 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 49.6% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pulmonary arterial hypertension (PAH) market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Wind Power Pitch Control System Market in China 2021
The wind power pitch control system market in China in terms of revenue is set to grow by US$ 32 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 1.1% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the wind power pitch control system market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Integrated Air Freight Forwarding Market in China 2021
The integrated air freight forwarding market in China in terms of revenue is set to grow by US$ 3 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the integrated air freight forwarding market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Pemetrexed Pharmaceutical Market in China 2021
The pemetrexed pharmaceutical market in China in terms of revenue is set to grow by US$ 443 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 10.1% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pemetrexed pharmaceutical market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Central Nervous System Pharmaceutical Market in China 2021
The central nervous system pharmaceutical market in China in terms of revenue is set to grow by US$ 10 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the central nervous system pharmaceutical market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Edaravone Pharmaceutical Market in China 2021
The edaravone pharmaceutical market in China in terms of revenue is expected to decline at a compound annual growth rate (CAGR) of -0.8% from US$ 426 million in 2020 to 429 million in 2027, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the edaravone pharmaceutical market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
-
Autoimmune Pharmaceutical Market in China 2021
The autoimmune pharmaceutical market in China in terms of revenue is set to grow by US$ 12 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 26.6% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the autoimmune pharmaceutical market to help drive informed decision making for industry executives, policy makers, academic, and analysts.